The drug does not represent a cure for pancreatic cancer, but its trial results are being viewed as a major development in the treatment of advanced disease. Common side effects reported by the FDA include rash, diarrhoea, mouth inflammation, nausea, fatigue, vomiting, abdominal pain, swelling, reduced appetite and bleeding.
